Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 90   

Articles published

NVO 45.77 +0.05 (0.11%)
price chart
EBOLA Endemic Should Be An Eye-Opener For The FDA
Another example is Tresiba, the long-acting insulin drug manufactured by Novo Nordisk A/S (ADR) (NYSE:NVO) to treat Type-1 diabetes.
Roche Holding Ltd.'s "Neutral" Rating Reaffirmed at Zacks (RHHBY)
The firm reiterated its neutral rating on shares of Novo Nordisk A/S (ADR). They have a $46.00 price target on that stock.
Related articles »  
Man Group Plc Price Target Increased to GBX 120 by Analysts at Morgan ...
The firm downgraded shares of Melco Crown Entertainment Ltd (ADR) from an overweight rating to an equal weight rating. Also, Morgan Stanley initiated coverage on shares of Novo Nordisk A/S (ADR). They issued an equal weight rating on that stock.
Related articles »  
Stocks in the Spotlight � C.H. Robinson Worldwide, (NASDAQ:CHRW),Biomed ...
Las Vegas, NV - September 18, 2014 - (Techsonian) - ValuePennyStocks.com provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages.
Related articles »  
Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares ...
Headquartered in Denmark, Novo Nordisk employs approximately. 40,700 employees in 75 countries, and markets its products in more than 180 countries.
Related articles »  
Zacks Reiterates Neutral Rating for Ericsson (ERIC)
The firm reiterated its neutral rating on shares of Novo Nordisk A/S (ADR). They have a $46.00 price target on that stock.
Related articles »  
Research Analysts' Ratings Reiterations for October, 13th (BAESY, BURBY ...
Novo Nordisk A/S (NYSE:NVO) had its neutral rating reiterated by analysts at Zacks. They currently have a $46.00 price target on the stock.
Related articles »  
BHP Billiton Limited's Overweight Rating Reiterated at Morgan Stanley (BHP)
The firm downgraded shares of Melco Crown Entertainment Ltd (ADR) from an overweight rating to an equal weight rating. Also, Morgan Stanley initiated coverage on shares of Novo Nordisk A/S (ADR). They issued an equal weight rating on that stock.
Related articles »  
Alacer Gold Corp - CDI Earns "Overweight" Rating from Morgan Stanley (AQG)
The firm downgraded shares of Melco Crown Entertainment Ltd (ADR) from an overweight rating to an equal weight rating. Also, Morgan Stanley initiated coverage on shares of Novo Nordisk A/S (ADR). They issued an equal weight rating on that stock.
Lululemon Athletica inc. Upgraded to "Neutral" at Zacks (LULU)
The firm reiterated its neutral rating on shares of Novo Nordisk A/S (ADR). They have a $46.00 price target on that stock.
Related articles »